Alongside our established bone and skin allograft business, Axiom Tissue partners with leading laboratories to bring three emerging biologic platforms — stem cells, NK cells, and exosomes — to qualified research programs and clinical partners across Greater China. 在成熟的骨与皮肤同种异体移植业务之外，雅信生物与领先实验室合作，将干细胞、NK 细胞及外泌体三大新兴生物技术平台，引入大中华地区合格的科研项目与临床合作伙伴。
Please note: 特别说明： advanced therapy products are distributed exclusively through research-use and approved clinical channels in accordance with local regulations in each market. Regulatory status varies by product and by jurisdiction. 先进疗法相关产品仅通过科研用途或经批准的临床渠道进行分发，并严格遵守各地法规要求。不同产品在不同司法辖区的监管状态可能有所不同。
Human mesenchymal stem cells (MSCs) sourced from umbilical cord, adipose, and bone marrow tissue. Our partner laboratories provide fully characterized, cryopreserved cell preparations for research and approved clinical programs. 人源间充质干细胞（MSC）来源涵盖脐带、脂肪及骨髓。我们的合作实验室提供经全面鉴定、深低温冻存的细胞制剂，服务于科研及已获批的临床项目。
Natural killer (NK) cells are the innate immune system's first responders — capable of recognizing and eliminating virus-infected and abnormal cells without prior sensitization. We partner on both peripheral-blood-derived and umbilical-cord-derived NK preparations. 自然杀伤（NK）细胞是固有免疫的"第一响应者"，无需预先致敏即可识别并清除受病毒感染或异常的细胞。我们合作提供来自外周血与脐带血两大来源的 NK 细胞制剂。
Exosomes are nano-scale extracellular vesicles carrying proteins, microRNAs, and other signaling molecules. They offer a cell-free approach to delivering regenerative signals — attractive for dermatology, musculoskeletal, and neurological research. 外泌体是纳米级的细胞外囊泡，携带蛋白、miRNA 及其他信号分子。作为"无细胞"的再生信号递送方式，其在皮肤、肌骨及神经系统研究中颇受关注。
Our advanced-therapy specialists can discuss product specifications, regulatory pathways, and collaboration models for Hong Kong, Mainland China, or Taiwan. 我们的先进疗法团队可就产品规格、法规路径及合作模式，为您提供香港、内地及台湾三地的定制化方案。
Request a Conversation 申请沟通